Overview

Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The main objective is to observe the effects of erythropoietin administration on different blood markers of ischaemic cardiac lesions induced by cardiopulmonary bypass.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Grenoble
Collaborator:
Roche Pharma AG
Treatments:
Epoetin Alfa